STAGE III

Clinical trials for STAGE III explained in plain language.

Never miss a new study

Get alerted when new STAGE III trials appear

Sign up with your email to follow new studies for STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy targets rare lung cancer mutation

Disease control Not yet recruiting

This study tests a new drug (firmonertinib) combined with radiation therapy for people with a specific type of stage III lung cancer that cannot be removed by surgery. The cancer must have a rare change in the EGFR gene. The goal is to see if the combination can delay cancer grow…

Matched conditions: STAGE III

Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

STAGE III

Get alerted when new STAGE III trials appear

New combo therapy targets rare lung cancer mutation